Literature DB >> 22966402

Hypoxia-inducible factor-1α enhances the malignant phenotype of multicellular spheroid HeLa cells in vitro.

Xun Tian1, Wei Wang, Qinghua Zhang, Liangping Zhao, Junchen Wei, Hui Xing, Yuping Song, Shixuan Wang, Ding Ma, Li Meng, Gang Chen.   

Abstract

The purpose of this study was to clarify the direct effect of hypoxia-inducible factor-1α (HIF-1α) on tumor growth, apoptosis and migration in vitro. To achieve this aim, a comparison was made of the differences in growth rates, apoptotic indices and cell invasive ability in the human cervical cancer cell line HeLa and the HIF-1α-blocked counterpart in a three-dimensional spheroid culture. A significant decrease in cell proliferation and invasion, and an increase in cell apoptosis were observed in HIF-1α-blocked cells in the three-dimensional culture. The data indicated that a multicellular spheroid culture is an ideal model of hypoxia in vitro and that HIF-1α is a significant regulator of adaptive processes that promote tumor cell malignant phenotypes, such as proliferation, anti-apoptosis and invasive ability.

Entities:  

Year:  2010        PMID: 22966402      PMCID: PMC3436219          DOI: 10.3892/ol_00000159

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.

Authors:  M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  Lysyl oxidase is essential for hypoxia-induced metastasis.

Authors:  Janine T Erler; Kevin L Bennewith; Monica Nicolau; Nadja Dornhöfer; Christina Kong; Quynh-Thu Le; Jen-Tsan Ashley Chi; Stefanie S Jeffrey; Amato J Giaccia
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.

Authors:  P Birner; M Schindl; A Obermair; C Plank; G Breitenecker; G Oberhuber
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

Review 5.  Harnessing the hypoxia-inducible factor in cancer and ischemic disease.

Authors:  M Christiane Brahimi-Horn; Jacques Pouysségur
Journal:  Biochem Pharmacol       Date:  2006-10-20       Impact factor: 5.858

6.  Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy.

Authors:  M I Koukourakis; A Giatromanolaki; J Skarlatos; L Corti; S Blandamura; M Piazza; K C Gatter; A L Harris
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

7.  Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism.

Authors:  Jian Chen; Songji Zhao; Kunihiro Nakada; Yuji Kuge; Nagara Tamaki; Futoshi Okada; Jingxin Wang; Masanobu Shindo; Fumihiro Higashino; Kohji Takeda; Masahiro Asaka; Hiroyuki Katoh; Toshio Sugiyama; Masuo Hosokawa; Masanobu Kobayashi
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

8.  Cyclin dependent kinase inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent pathway.

Authors:  Gang Wang; Richard Reisdorph; Robert E Clark; Robin Miskimins; Ronald Lindahl; W Keith Miskimins
Journal:  J Cell Biochem       Date:  2003-10-15       Impact factor: 4.429

9.  Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor.

Authors:  Gisele Höpfl; Roland H Wenger; Urs Ziegler; Thomas Stallmach; Olivier Gardelle; Roger Achermann; Melanie Wergin; Barbara Kaser-Hotz; H Mark Saunders; Kaye J Williams; Ian J Stratford; Max Gassmann; Isabelle Desbaillets
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

10.  Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.

Authors:  A Giatromanolaki; M I Koukourakis; E Sivridis; H Turley; K Talks; F Pezzella; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

View more
  3 in total

1.  Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs.

Authors:  Ekaterina Schreiber-Brynzak; Erik Klapproth; Christine Unger; Irene Lichtscheidl-Schultz; Simone Göschl; Sarah Schweighofer; Robert Trondl; Helmut Dolznig; Michael A Jakupec; Bernhard K Keppler
Journal:  Invest New Drugs       Date:  2015-06-21       Impact factor: 3.850

2.  High variability of genomic instability and gene expression profiling in different HeLa clones.

Authors:  Annalisa Frattini; Marco Fabbri; Roberto Valli; Elena De Paoli; Giuseppe Montalbano; Laura Gribaldo; Francesco Pasquali; Emanuela Maserati
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

3.  Effects of hypoxia inducible factor-1α on apoptotic inhibition and glucocorticoid receptor downregulation by dexamethasone in AtT-20 cells.

Authors:  Chenran Zhang; Qiang Qiang; Ying Jiang; Liuhua Hu; Xuehua Ding; Yicheng Lu; Guohan Hu
Journal:  BMC Endocr Disord       Date:  2015-05-23       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.